Antiprogestin and/or gonadotropin-releasing hormone agonist for endometriosis treatment and bone maintenance: a 1-year primate study

Condition tags

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (12)

• Antiprogestins in gynecological diseases 2014
• [Interest of selective progesterone receptor modulators in endometriosis] 2013
• Progesterone Resistance and Targeting the Progesterone Receptors: A Therapeutic Approach to Endometriosis 2012
• The immninent dawn of SPRMs in obstetrics and gynecology 2012
• Tratamiento de la endometriosis con 5mg o 25mg diarios de mifepristona durante 6 meses. Ensayo clínico aleatorizado, doble ciego 2011
• The role of progestins in treating the pain of endometriosis 2006
• Hormonal regulation and localization of estrogen, progestin and androgen receptors in the endometrium of nonhuman primates: effects of progesterone receptor antagonists 2004
• Animal studies in endometriosis: a review 2004
• Progesterone antagonists and progesterone receptor modulators: an overview 2003
• Medical Therapy for Endometriosis 2003
• The role of selective oestrogen receptor modulators in the treatment of endometrial bleeding in women using long-acting progestin contraception 2000
• Modern medical management of endometriosis 1997

Source provenance

openalex

last seen: 2026-06-10T17:14:06.276822+00:00

unpaywall

last seen: 2026-10-13T06:25:51.201866+00:00